Vascular Pharmaceuticals Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Out of Business

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Out of Business

Vascular Pharmaceuticals General Information

Description

Developer of diabetic therapeutic drugs intended to address complications arising from diabetes. The company's drugs feature monoclonal antibody that binds to a unique molecular target within the αVβ3 receptor for the treatment of type 1 and type 2 diabetes, enabling patients to avoid the complications resulting from diabetes and diabetic nephropathy.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 79 TW Alexander Drive, Research Commons, Building 4401
  • Suite 200A, Research Triangle Park
  • Durham, NC 27709
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 79 TW Alexander Drive, Research Commons, Building 4401
  • Suite 200A, Research Triangle Park
  • Durham, NC 27709
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vascular Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Out of Business 01-Jul-2017 Completed Out of Business
4. Later Stage VC (Series A) 06-Jan-2016 Completed Clinical Trials - Phase 2
3. Later Stage VC (Series A) 21-Jan-2015 Completed Generating Revenue
2. Later Stage VC (Series A) 10-Sep-2012 $16M $16M Completed Generating Revenue
1. Grant 01-Jan-2012 $1.6M Completed Generating Revenue
To view Vascular Pharmaceuticals’s complete valuation and funding history, request access »

Vascular Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view Vascular Pharmaceuticals’s complete cap table history, request access »

Vascular Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of diabetic therapeutic drugs intended to address complications arising from diabetes. The company's drugs fea
Drug Discovery
Durham, NC
7 As of 2016

Monterey, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Vascular Pharmaceuticals Competitors (1)

One of Vascular Pharmaceuticals’s competitors is Vybion, a Formerly VC-backed company based in Monterey, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Vybion Formerly VC-backed Monterey, CA
You’re viewing 1 of 1 competitors. Get the full list »

Vascular Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Vascular Pharmaceuticals FAQs

  • When was Vascular Pharmaceuticals founded?

    Vascular Pharmaceuticals was founded in 2005.

  • Where is Vascular Pharmaceuticals headquartered?

    Vascular Pharmaceuticals is headquartered in Durham, NC.

  • What is the size of Vascular Pharmaceuticals?

    Vascular Pharmaceuticals has 7 total employees.

  • What industry is Vascular Pharmaceuticals in?

    Vascular Pharmaceuticals’s primary industry is Drug Discovery.

  • Is Vascular Pharmaceuticals a private or public company?

    Vascular Pharmaceuticals is a Private company.

  • What is Vascular Pharmaceuticals’s current revenue?

    The current revenue for Vascular Pharmaceuticals is .

  • How much funding has Vascular Pharmaceuticals raised over time?

    Vascular Pharmaceuticals has raised $29M.

  • Who are Vascular Pharmaceuticals’s competitors?

    Vybion is a competitor of Vascular Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process